Skip to main content
TipRanks
Go Ultimate75% OFF

Resmed (RMD) Revenue by Segment

1,215 Followers

Revenue by Segment

Resmed reported revenue by segment of $1.41B in Q1 FY2027, down 3.4% from Q4 FY2026 and up 5.9% year over year. The highest value was $1.46B in Q4 FY2026.

Breaks down overall revenue into specific business segments, providing insight into which parts of the company are performing well and contributing most to the bottom line.

$0.00$250.00M$500.00M$750.00M$1.00B$1.25B$1.50BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

ResMed’s mix is shifting: the Sleep & Breathing franchise remains the revenue backbone with durable product/resupply momentum, while Residential Care Software is the faster-growing, higher‑margin engine—accelerating after recent M&A and product rollouts. Management’s FY27 guidance strips MatrixCare and flags a suspended Astral ventilator program, so reported growth and near‑term EPS will be modestly depressed even as core revenue and gross‑margin expansion persist. In short, underlying recurring software and mask/device replacement trends are sound, but Astral provisions and the MatrixCare divestiture introduce near‑term noise.

RMD Revenue by Segment

PeriodSleep and Breathing Health ProductsResidential Care SoftwareTotal
Q1 FY2027Sep 30, 2026$1.26B$155.01M$1.41B
Q4 FY2026Jun 30, 2026$1.29B$172.00M$1.46B
Q3 FY2026Mar 31, 2026$1.26B$170.89M$1.43B
Q2 FY2026Dec 31, 2025$1.26B$166.90M$1.42B
Q1 FY2026Sep 30, 2025$1.17B$166.10M$1.34B
Q4 FY2025Jun 30, 2025$1.18B$167.00M$1.35B
Q3 FY2025Mar 31, 2025$1.13B$161.20M$1.29B
Q2 FY2025Dec 31, 2024$1.13B$156.50M$1.28B
Q1 FY2025Sep 30, 2024$1.07B$156.77M$1.22B
Q4 FY2024Jun 30, 2024$1.07B$151.90M$1.22B
Q3 FY2024Mar 31, 2024$1.05B$147.96M$1.20B
Q2 FY2024Dec 31, 2023$1.02B$144.95M$1.16B
Q1 FY2024Sep 30, 2023$963.04M$139.28M$1.10B
Q4 FY2023Jun 30, 2023$983.50M$138.60M$1.12B
Q3 FY2023Mar 31, 2023$980.12M$136.78M$1.12B
Q2 FY2023Dec 31, 2022$916.98M$116.76M$1.03B
Q1 FY2023Sep 30, 2022$844.44M$105.85M$950.29M
Q4 FY2022Jun 30, 2022$811.60M$103.10M$914.70M
Q3 FY2022Mar 31, 2022$763.36M$101.14M$864.50M
Q2 FY2022Dec 31, 2021$795.84M$99.03M$894.87M
Q1 FY2022Sep 30, 2021$806.50M$97.52M$904.01M
Q4 FY2021Jun 30, 2021$780.30M$95.80M$876.10M
Q3 FY2021Mar 31, 2021$674.93M$93.84M$768.77M
Q2 FY2021Dec 31, 2020$708.18M$91.83M$800.01M
Q1 FY2021Sep 30, 2020$659.80M$92.14M$751.94M
Q4 FY2020Jun 30, 2020$678.90M$91.50M$770.40M
Q3 FY2020Mar 31, 2020$679.89M$89.56M$769.46M
Q2 FY2020Dec 31, 2019$649.50M$86.70M$736.20M
Q1 FY2020Sep 30, 2019$594.20M$86.90M$681.10M
Q4 FY2019Jun 30, 2019$619.80M$85.20M$705.00M
Q3 FY2019Mar 31, 2019$582.30M$79.90M$662.20M

Related KPIs